Ecrins Therapeutics
About:
Discovering new drugs is both our profession and our passion.
Website: http://ecrins-therapeutics.com/en/home/
Twitter/X: ecrinsth
Top Investors: Eurostars
Description:
Ecrins Therapeutics is a privately held biotech company specialized in the discovery and development of innovative oncology drugs. Our main drug candidate ET-D5 is being developped for human and veterinary oncology applications and is currently in the regulatory preclinical phase. Our other R&D programs are in the discovery phase.
Total Funding Amount:
$2.67M
Headquarters Location:
Grenoble, Rhone-Alpes, France
Founded Date:
2010-01-01
Contact Email:
info(AT)ecrins-therapeutics.com
Founders:
Andreï Popov
Number of Employees:
1-10
Last Funding Date:
2015-05-11
IPO Status:
Private
Industries:
© 2025 bioDAO.ai